Asthma Drug Fluticasone Fails as Potential COVID Treatment
THURSDAY, July 14, 2022 (HealthDay News) — The asthma drug fluticasone furoate is yet another medication that doesn’t work for mild-to-moderate COVID-19, a new study finds. “There was no evidence of improvement in time to recovery or reduction in hospitalizations in participants who took fluticasone furoate versus those who tookContinue Reading